Bharath Life Science India Private Limited

Bharath Life Science India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U51397TG2014PTC092818 Incorporated 07 February 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2022
₹2.09 Lakh
▼ 54% YoY
Net loss · FY 2022
₹18,601
Net margin -8.9%
EBITDA · FY 2022
₹20,183
EBITDA margin 9.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Bharath Life Science India Private Limited

Data last updated:

Bharath Life Science India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51397TG2014PTC092818. Its GSTIN is 36AAFCB8292D1ZL (Telangana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Narmada Nandyala and Venkata Prabhakar Reddy Gorla.

Its last annual general meeting (AGM) was held on 27 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2022, the company reported a revenue of ₹2.09 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹18,601 (net margin -8.9%) and EBITDA of ₹20,183 (EBITDA margin 9.7%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years and 44% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bharathlifescience.com.

Company details

CIN U51397TG2014PTC092818
Registration Number 092818
Incorporation Date 07 February 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Bharath Life Science India has one previous CIN (Corporate Identification Number): U51397AP2014PTC092818. The current CIN is U51397TG2014PTC092818, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397TG2014PTC092818Current
U51397AP2014PTC092818Previous

Contact details

Bharath Life Science India Private Limited's registered office is in Hyderabad, Telangana. Its website is bharathlifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 29&33 H.No.5 – 207/A Room No 101 Chanda Nagar Chinthal Quthbullapur Cir, Cle Ghmc, Hyderabad, Telangana, India – 500054
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bharath Life Science India Private Limited, buy the company report.

Comprehensive company report
Bharath Life Science India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bharath Life Science India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Bharath Life Science India Private Limited, buy the company report.

Financials of Bharath Life Science India Private Limited

FY 2022 filings available

Bharath Life Science India Private Limited reported revenue of ₹2.09 Lakh (down 54% YoY) for FY 2022.

Revenue · FY 2022
₹2.09 Lakh ▼ 54%
Net loss · FY 2022
₹18,601 margin -8.9%
EBITDA · FY 2022
₹20,183 margin 9.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▼ 42%
5 years · compounded
▼ 44%
EBITDA CAGR growth
1 year
▼ 63%
3 years · compounded
▼ 22%
5 years · compounded
▼ 26%

Revenue has declined at a compounded annual rate (CAGR) of 44% over five years, including a 54% fall in the latest year. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹2.09 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹20,183
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹18,601
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin9.7%
Net Profit Margin-8.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bharath Life Science India Private Limited, buy the company report.

Board of directors of Bharath Life Science India Private Limited

Bharath Life Science India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narmada NandyalaDirector23 Mar 20206 Years 7 MonthsCurrent
Venkata Prabhakar Reddy GorlaDirector07 Feb 201412 Years 9 MonthsCurrent
Sudhakar Reddy NandyalaDirector07 Feb 201412 Years 9 MonthsCurrent

Auditor

Bharath Life Science India Private Limited is audited by KANUMARLA & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
KANUMARLA & ASSOCIATESFY 2017011250S

Shareholding

The shareholding of Bharath Life Science India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bharath Life Science India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bharath Life Science India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bharath Life Science India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAFCB8292D1ZLTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Bharath Life Science India Private Limited, buy the company report.

Recent activity

Bharath Life Science India Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Kommuri Suresh Babu ceased to be Director on 23 Mar 2020.

AGM
Bharath Life Science India Private Limited last Annual general meeting of members was held on 27 Sep 2022 as per latest MCA records.
Filing
Bharath Life Science India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Ceased
Kommuri Suresh Babu ceased to be Director.
Appointed
Narmada Nandyala was appointed as Director.
Ceased
Venkata Krishna Reddy Chittireddy ceased to be Director.
Appointed
Sudhakar Reddy Nandyala was appointed as Director.
Appointed
Venkata Prabhakar Reddy Gorla was appointed as Director.
Incorporation
07 Feb 2014
Bharath Life Science India Private Limited was registered on 07 Feb 2014 with Roc Hyderabad & aged 12 years 9 months as per MCA records.

Frequently asked questions

Bharath Life Science India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 February 2014 (12+ years old) and is registered under CIN U51397TG2014PTC092818.

Bharath Life Science India has 3 current directors:

The latest financial statements of Bharath Life Science India on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 27 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Bharath Life Science India is 36AAFCB8292D1ZL, registered in Telangana.

The CIN (Corporate Identification Number) of Bharath Life Science India is U51397TG2014PTC092818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bharath Life Science India was incorporated on 07 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

Kommuri Suresh Babu ceased to be Director on 23 Mar 2020. Narmada Nandyala was appointed as Director on 23 Mar 2020. Venkata Krishna Reddy Chittireddy ceased to be Director on 23 Mar 2020. Bharath Life Science India has 5 board changes on record in total.

Bharath Life Science India can be reached through the website bharathlifescience.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Bharath Life Science India is at Plot No. 29&33 H.No.5 – 207A Room No 101 Chanda Nagar Chinthal Quthbullapur Cir, Cle Ghmc, Hyderabad, Telangana, India – 500054.

Bharath Life Science India operates in the pharma industry, in the drug formulation and development segment.